John William Wulf is Director at agilon health, inc. (AGL). They have made 5 open-market trades across 1 company since 2021, most recently 2026-06-02.
CIK 0001856345
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $149K since 2024, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AGL | 16,765 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2026-06-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGL | BUY | 2025-11-12 | 2026-01-30 | $0.63 | $51K | -57.3% | -30.8% | +3044.4% |
| AGL | BUY | 2024-12-05 | 2024-12-11 | $2.18 | $98K | -11.5% | +16.3% | +84.2% |
| AGL | SELL | 2023-03-15 | 2023-03-17 | $23.82 | $1.9M | +2.8% | +5.3% | -28.2% |
| AGL | SELL | 2022-03-15 | 2022-03-16 | $19.09 | $964K | +21.6% | +12.5% | -5.2% |
| AGL | SELL | 2021-09-14 | 2021-09-15 | $28.98 | $889K | -12.6% | -22.4% | -27.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.